Cathay Biotech Inc (688065) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Cathay Biotech Inc (688065) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-66.22 Million ≈ $-9.69 Million USD) by net assets (CN¥21.22 Billion ≈ $3.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cathay Biotech Inc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Cathay Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688065 liabilities breakdown for a breakdown of total debt and financial obligations.

Cathay Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cathay Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sectra AB (publ) ST:SECT-B	0.023x
Glarun Technology Co Ltd SHG:600562	-0.001x
Beijing Jingneng Power Co Ltd SHG:600578	0.127x
Genesis Minerals Ltd AU:GMD	0.256x
CHINA TOWER UNSP.ADR/100 F:2Y10	N/A
Housing & Urban Development Corporation Limited NSE:HUDCO	-1.041x
Corporacion Financiera Alba SA MC:ALB	0.006x
Red Avenue New Materials Group Co Ltd SHG:603650	0.058x

Annual Cash Flow Conversion Efficiency for Cathay Biotech Inc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Cathay Biotech Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Cathay Biotech Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥15.10 Billion ≈ $2.21 Billion	CN¥820.93 Million ≈ $120.13 Million	0.054x	+41.03%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥569.45 Million ≈ $83.33 Million	0.039x	-27.87%
2022-12-31	CN¥15.04 Billion ≈ $2.20 Billion	CN¥803.67 Million ≈ $117.60 Million	0.053x	+32.10%
2021-12-31	CN¥14.69 Billion ≈ $2.15 Billion	CN¥594.18 Million ≈ $86.95 Million	0.040x	-9.78%
2020-12-31	CN¥11.48 Billion ≈ $1.68 Billion	CN¥514.96 Million ≈ $75.36 Million	0.045x	-42.12%
2019-12-31	CN¥4.64 Billion ≈ $679.25 Million	CN¥359.62 Million ≈ $52.62 Million	0.077x	+2477.46%
2018-12-31	CN¥3.16 Billion ≈ $461.93 Million	CN¥-10.29 Million ≈ $-1.51 Million	-0.003x	-113.39%
2017-12-31	CN¥2.20 Billion ≈ $321.46 Million	CN¥53.45 Million ≈ $7.82 Million	0.024x	+123.05%
2016-12-31	CN¥1.22 Billion ≈ $178.35 Million	CN¥-128.67 Million ≈ $-18.83 Million	-0.106x	--

About Cathay Biotech Inc

SHG:688065 China Chemicals

Market Cap

$5.02 Billion

CN¥34.33 Billion CNY

Market Cap Rank

#3614 Global

#578 in China

Share Price

CN¥47.60

Change (1 day)

-0.56%

52-Week Range

CN¥45.43 - CN¥62.24

All Time High

CN¥134.07